In conclusion, to our best knowledge, this is the first study to show that patients with ACS and concomitant UCOPD have increased endothelial dysfunction and on-treatment platelet reactivity. Moreover, we showed that ticagrelor may contribute to improve both parameters. Accordingly, any further effort for early identification and treatment of patients with UCOPD should be encouraged.

Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial

PAVASINI, Rita
Primo
;
VIECELI DALLA SEGA, Francesco;GALLO, Francesco;Passarini, Giulia;PAPI, Alberto;CONTOLI, Marco;CAMPO, Gianluca Calogero
2017

Abstract

In conclusion, to our best knowledge, this is the first study to show that patients with ACS and concomitant UCOPD have increased endothelial dysfunction and on-treatment platelet reactivity. Moreover, we showed that ticagrelor may contribute to improve both parameters. Accordingly, any further effort for early identification and treatment of patients with UCOPD should be encouraged.
Pavasini, Rita; VIECELI DALLA SEGA, Francesco; Gallo, Francesco; Passarini, Giulia; Papi, Alberto; Contoli, Marco; Campo, Gianluca Calogero
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2376548
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact